Stacey M. Anderson, MD
Graduate School: Vanderbilt University
Primary Appointment: Research Assistant Professor, Medicine, Endocrinology and Metabolism
Type 1 diabetes and hypoglycemia
Email Address: email@example.com
Dr. Anderson serves as the Medical Director of the UVA Center for Diabetes Technology. She is an adult endocrinologist and research physician who has conducted numerous hospital-based clinical trials, including over 100 hyperinsulinemic clamp procedures involving algorithmic blood glucose control. She is the clinician in charge of running the artificial pancreas studies at the University of Virginia and has published papers evaluating the accuracy of continuous glucose monitors. She has clinical expertise in the treatment and management of Type 1 Diabetes Mellitus and has taught Type 1 diabetes management to second year medical students in the Practice of Medicine course and routinely treats T1DM patients in her practice who use insulin pumps and continuous glucose monitors.
Chan A, Barrett EJ, Anderson SM, Kovatchev BP, Breton MD. Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus. Diabetologia. 2012 Mar;55(3):729-36. doi: 10.1007/s00125-011-2402-3. Epub 2011 Dec 14.
Farhy LS, Chan A, Breton MD, Anderson SM, Kovatchev BP, McCall AL. Association of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetes. Front Physiol. 2012;3:40. doi: 10.3389/fphys.2012.00040. Epub 2012 Feb 28.
Chan A, Kovatchev BP, Anderson SM, Breton MD. Systematic method to assess microvascular recruitment using contrast-enhanced ultrasound. Application to insulin-induced capillary recruitment in subjects with T1DM. Comput Methods Programs Biomed. 2011 May;102(2):219-26. doi: 10.1016/j.cmpb.2010.03.008. Epub 2010 Apr 30.
Pitsillides AN, Anderson SM, Kovatchev B. Hypoglycemia risk and glucose variability indices derived from routine self-monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counterregulation. Diabetes Technol Ther. 2011 Jan;13(1):11-7. doi: 10.1089/dia.2010.0103.
|Office Address:||PO Box 801414, Charlottesville, VA 22908-1414
|Office Phone:||+1 434-924-1825|
|Fax Phone:||+1 434-924-9616|